A recent study found that mothers of twins are at double the risk of heart disease in the year after giving birth compared to mothers who give birth to a single infant. The research, led by Professor ...

Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

New moms who just have had twins run a high risk of heart disease in the next weeks and months, a new study suggests.

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, me ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

In its current form, SNAP operates as a de facto subsidy program that props up some of the unhealthiest parts of the food ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

Still, the adult obesity rate in the U.S. is 42.4% vs. 14% in China—though it’s expected to rise along with interest in fast ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick ...

Hawaii ranked among the top 10 states for high health rankings, according to a recently released report by the United Health Foundation. Hawaii ranked eighth-best among states in key health measures, ...